Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Prevalence and clinical correlates of obsessive-compulsive disorder in central nervous system autoimmune demyelinating diseases: A cross-sectional observational Study

AI Summary
  • OCD prevalence was 15.4% in MS (highest in RRMS 17.8%) and 12.7% in NMOSD among 4,759 patients.
  • Higher odds of OCD associated with female sex, higher education, sensory onset, migraine, hypothyroidism, lower EDSS and shorter disease duration.
  • Findings underscore need to recognise and address psychiatric comorbidity in MS and NMOSD to enable comprehensive, individualised clinical management.
Summarise with AI (MRCPsych/FRANZCP)

Sage Open Chronic Dis. 2026 Sep 11;17:27558428261484092. doi: 10.1177/27558428261484092. eCollection 2026 Jan-Dec.

ABSTRACT

BACKGROUND: Obsessive-compulsive disorder (OCD) is a disabling psychiatric comorbidity that may be underrecognized in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Evidence regarding its prevalence and associated factors in these populations remains limited.

OBJECTIVES: To estimate the prevalence of OCD and examine its clinical and demographic correlates in patients with MS and NMOSD in an Iranian cohort.

DESIGN: Cross-sectional observational study.

METHODS: This cross-sectional study (January 2018-December 2024) included patients with MS and NMOSD from Kashani Hospital and Hakim MS Clinic, Isfahan, Iran. MS and NMOSD diagnoses were made according to the 2017 McDonald and 2015 IPND criteria, respectively. OCD was diagnosed by certified psychiatrists per DSM-IV. Demographic, clinical, and neuropsychological data were extracted from interviews and medical records. Group comparisons were performed using t-tests or χ2 tests, followed by univariate and multivariate logistic regression analyses.

RESULTS: Of 4,759 patients (mean age, 42.9 years; 77.1% female), 4,460 had MS (3,502 with relapsing-remitting MS (RRMS), 212 with primary progressive MS (PPMS), and 746 with secondary progressive MS (SPMS)), and 299 had NMOSD. OCD prevalence was 15.4% in MS, highest in RRMS (17.8%), and 12.7% in NMOSD. Across all participants, female sex (OR 1.32, 95% CI 1.04-1.64), higher educational attainment, sensory vs. motor onset symptoms, migraine (OR 1.46, 95% CI 1.16-1.83), and hypothyroidism (OR 1.29, 95% CI 1.01-1.65), lower EDSS (OR per 1-unit: 0.78, 95% CI 0.70 – 0.88), and shorter disease duration (OR per 1-year: 0.98, 95% CI 0.97 – 1.00) were significantly associated with higher odds of OCD.

CONCLUSION: OCD is frequently observed among patients with MS and NMOSD and shows distinct clinical associations, including migraine, hypothyroidism, sensory onset phenotype, and lower disability. Recognition of psychiatric comorbidities in these disorders may facilitate more comprehensive and individualized clinical management.

PMID:43034404 | PMC:PMC13768615 | DOI:10.1177/27558428261484092

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD